Targeting EGFR mutant tyrosine kinase inhibitors (TKIs) resistant and drug-tolerant persister cells in non-small cell lung cancer (NSCLC)
-
Award Number: R50CA265307
-
ORGANIZATION: NATIONAL CANCER INSTITUTE
-
OPDIV: NIH
-
AWARD CLASS: DISCRETIONARY
-
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
-
PERIOD OF PERFORMANCE START DATE: 09/21/2021
-
PERIOD OF PERFORMANCE END DATE: 08/31/2026